A polymorphism within the connective tissue growth factor (CTGF) gene has no effect on non-invasive markers of beta-cell area and risk of type 2 diabetes

Disease Markers

Volumn 31, Issue 4, 2011, Pages 241-246

  Pivovarova, Olga ^a,b   Fisher, Eva ^a   Dudziak, Katarzyna ^c,d   Ilkavets, Iryna ^e   Dooley, Steven ^e   Slominsky, Petr ^f   Limborska, Svetlana ^f   Weickert, Martin O ^a,b,g,h   Spranger, Joachim ^a,b   Fritsche, Andreas ^c,d   Boeing, Heiner ^a   Pfeiffer, Andreas F H ^a,b   Rudovich, Natalia ^a,b  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

^g UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^h UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

beta cell mass; blood glucose; C peptide; connective tissue growth factor gene; Genetic association; type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; CONNECTIVE TISSUE GROWTH FACTOR; GLUCOSE;

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GERMANY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

MUS;

EID: 81055144310     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0823     Document Type: Article

References (26)

1. C. Shtir, I.S. Nagakawa, W.L. Duren et al., Subsets of Finns with high HDL to total cholesterol ratio show evidence for linkage to type 2 diabetes on chromosome 6q, Hum Hered 63 (2007), 17-25. (Pubitemid 46192726)
2. R. Duggirala, J. Blangero, L. Almasy et al., A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesityrelated phenotypes in non-diabetic Mexican Americans, Am J Hum Genet 68 (2001), 1149-1164. (Pubitemid 32424414)
3. K. Xiang, Y. Wang, T. Zheng et al., Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese, Diabetes 53 (2004), 228-234.
4. R. Baratta, P. Rossetti, S. Prudente et al., Role of the ENPP1 K121Q polymorphism in glucose homeostasis, Diabetes 57 (2008), 3360-3364.
5. K.J. Gaulton, C.J. Willer, Y. Li et al., Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes, Diabetes 57 (2008), 3136-3144.
6. J.B.McAteer, S. Prudente, S. Bacci et al., ENPP1 Consortium, The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects, Diabetes 57 (2008), 1125-1130.
7. S. Mercurio, B. Latinkic, N. Itasaki et al., Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex, Development 131 (2004), 2137-2147. (Pubitemid 38702045)
8. L.A. Crawford, M.A. Guney, Y.A. Oh et al., Connective tissue growth factor (CTGF) inactivation leads to defects in islet cell lineage allocation and beta-cell proliferation during embryogenesis, Mol Endocrinol 23 (2009), 324-336.
9. S.M. Twigg, Z. Cao, S.V. MCLennan et al., Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine, Endocrinology 143 (2002), 4907-4915. (Pubitemid 35397630)
10. R. Candido, K.A. Jandeleit-Dahm, Z. Cao et al., Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice, Circulation 106 (2002), 246-253. (Pubitemid 34761307)
11. K.J.Way, K. Isshiki, K. Suzuma et al., Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes, Diabetes 51 (2002), 2709-2718. (Pubitemid 34970923)
12. O.K. Hong, S.H. Lee, M. Rhee et al., Hyperglycemia and hyperinsulinemia have additive effects on activation and proliferation of pancreatic stellate cells: possible explanation of isletspecific fibrosis in type 2 diabetes mellitus, J Cell Biochem 101 (2007), 665-675. (Pubitemid 46698851)
13. M.B. Omary, A. Lugea, A.W. Lowe et al., The pancreatic stellate cell: a star on the rise in pancreatic diseases, J Clin Invest 117 (2007), 50-59. (Pubitemid 46048449)
14. J.W. Kim, S.H. Ko, J.H. Cho et al., Loss of beta-cells with fibrotic islet destruction in type 2 diabetes mellitus, Front Biosci 13 (2008), 6022-6033.
15. R. Gao and D.R. Brigstock, Connective tissue growth factor (CCN2) in rat pancreatic stellate cell function: integrin alpha5beta1 as a novel CCN2 receptor, Gastroenterology 129 (2005), 1019-1030. (Pubitemid 41242692)
16. J.J. Meier, B.A. Menge, T.G. Breuer et al., Functional assessment of pancreatic beta-cell area in humans, Diabetes 58 (2009), 1595-1603.
17. H. Boeing, A. Korfmann and M.M. Bergmann, Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition, Ann Nutr Metab 43 (1999), 205-215.
18. M.M. Bergmann, U. Bussas and H. Boeing, Follow-up procedures in EPIC-Germany-data quality aspects. European Prospective Investigation into Cancer and Nutrition, Ann Nutr Metab 43 (1999), 225-234.
19. M.B. Schulze, H. Al-Hasani, H. Boeing et al., Variation in the HHEX-IDE gene region predisposes to type 2 diabetes in the prospective, population-based EPIC-Potsdam cohort, Diabetologia 50 (2007), 2405-2407. (Pubitemid 47512391)
20. N. Rudovich, O. Pivovarova, E. Fisher et al., Polymorphisms within insulin degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes, J MolMed 87 (2009), 1145-1151.
21. M.B. Schulze, K. Hoffmann, H. Boeing et al., An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes, Diabetes Care 30 (2007), 510-515. (Pubitemid 46354326)
22. E. Kovalenko, F. Tacke, O.A. Gressner et al., Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis, J Viral Hepat 16 (2009), 612-620.
23. I.E. Blom, A.J. van Dijk, R.A. de Weger et al., Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms, Mol Pathol 54 (2001), 192-196. (Pubitemid 32539613)
24. W.E. Barlow, L. Ichikawa, D. Rosner et al., Analysis of casecohort designs, J Clin Epidemiol 52 (1999), 1165-1172.
25. R. Saxena,M.F.Hivert, C. Langenberg et al., Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge, Nat Genet 42 (2010), 142-148.
26. J. Dupuis, C. Langenberg, I. Prokopenko et al., New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk, Nat Genet 42 (2010), 105-116.